Two-year OS with immunotherapy in patients with distant metastatic disease was higher, although this did not reach statistical significance (33% vs. 12%, p=0.054).
← all excerpts
Vulvar melanoma: an analysis of prognostic factors and treatment patterns.
1
0.0540
0.0540